<div id="readability-page-1"><div> By Katherine Hamilton <pre></pre> Micron Technology recorded a jump in sales and raised some of its expectations for demand growth in coming months. The stock gained 7.7%, to $242.86, in after-hours trading Wednesday. MillerKnoll's third-quarter forecast was ahead of Wall Street estimates. Shares rose 8.7%, to $19.05, after the bell. HireQuest authorized a $20 million share-buyback program. The stock rose 5%, to $8.12. Insmed said it would discontinue the development of its treatment for rhinosinusitis after the drug failed to meet primary and secondary endpoints. Shares slid 19%, to $160.18. <pre></pre> Write to Katherine Hamilton at katherine.hamilton@wsj.com <pre></pre> (END) Dow Jones Newswires December 17, 2025 18:50 ET (23:50 GMT)Copyright (c) 2025 Dow Jones &amp; Company, Inc.</div></div>

INSM

美光科技

MLKN

美光科技的銷售增長導致股價上漲 7.7%。MillerKnoll 的預測超出預期，推動股價上漲 8.7%。HireQuest 宣佈進行 2000 萬美元的股票回購，股價上漲 5%。Insmed 停止了一項藥物開發，導致股價下跌 19%

Stocks to Watch: Micron, MillerKnoll, HireQuest, Insmed

- Micron Technology 銷售增長，預期需求改善，股價漲 7.7%，報 $242.86。  
- MillerKnoll 第三季度預測超出預期，股價漲 8.7%，報 $19.05。  
- Insmed 停止開發藥物，股價跌 19%，報 $160.18。

值得關注的股票：美光科技、MillerKnoll、HireQuest、Insmed